CHAMPIONS ONCOLOGY, INC. (CSBR) Shareholder Equity
- 2026-07-31: Common Stock, Value, IssuedUSD $14.00K; Additional Paid in Capital, Common StockUSD $86.08M; Treasury Stock, Common, ValueUSD $708.00K; Retained Earnings (Accumulated Deficit)USD $-81.49M.
- 2026-04-30: Common Stock, Value, IssuedUSD $14.00K; Additional Paid in Capital, Common StockUSD $85.70M; Treasury Stock, Common, ValueUSD $708.00K; Retained Earnings (Accumulated Deficit)USD $-81.07M.
- 2026-01-31: Common Stock, Value, IssuedUSD $14.00K; Additional Paid in Capital, Common StockUSD $85.38M; Treasury Stock, Common, ValueUSD $708.00K; Retained Earnings (Accumulated Deficit)USD $-80.40M.
- 2025-10-31: Common Stock, Value, IssuedUSD $14.00K; Additional Paid in Capital, Common StockUSD $84.98M; Treasury Stock, Common, ValueUSD $708.00K; Retained Earnings (Accumulated Deficit)USD $-80.12M.
CHAMPIONS ONCOLOGY, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Treasury Stock, Common, Value USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | Treasury Stock, Value, Acquired, Cost Method USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Treasury Stock, Shares, Acquired shares | Treasury Stock Acquired, Average Cost Per Share USD/shares | Preferred Stock, Value, Issued USD | Additional Paid in Capital USD | Treasury Stock, Value USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Treasury Stock, Shares shares |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-31 | $14.00K | $86.08M | $708.00K | $-81.49M | $3.89M | $4.46M | 40 month · $708.00K | 3 month · $766.00K | 40 month · 120.30K | 40 month · 5.73 | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-04-30 | $14.00K | $85.70M | $708.00K | $-81.07M | $3.94M | $4.07M | 37 month · $708.00K | 12 month · $1.24M | 37 month · 120.30K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-01-31 | $14.00K | $85.38M | $708.00K | $-80.40M | $4.28M | $4.38M | 34 month · $708.00K | 3 month · $423.00K | 34 month · 120.30K | 34 month · 5.73 | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-10-31 | $14.00K | $84.98M | $708.00K | $-80.12M | $4.17M | $4.23M | 31 month · $708.00K | 3 month · $249.00K | 31 month · 120.30K | 31 month · 5.73 | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-07-31 | $14.00K | $84.56M | $708.00K | $-80.36M | $3.51M | $3.54M | 28 month · $708.00K | 3 month · $208.00K | 28 month · 120.30K | 28 month · 5.73 | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-04-30 | $14.00K | $84.36M | $708.00K | $-79.89M | $3.77M | $3.77M | 25 month · $708.00K | 12 month · $654.00K | 25 month · 120.30K | 25 month · 5.73 | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-01-31 | $14.00K | $84.22M | $708.00K | $-78.06M | $5.47M | $5.47M | (m) | 3 month · $256.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-10-31 | $14.00K | $83.93M | $708.00K | $-82.55M | $681.00K | $681.00K | 19 month · $708.00K | 3 month · $9.00K | 19 month · 120.33K | 19 month · 5.73 | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-07-31 | $14.00K | $83.64M | $708.00K | $-83.28M | $-332.00K | $-332.00K | 3 month · $708.00K | 3 month · $258.00K | 3 month · 120.33K | 3 month · 5.73 | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-04-30 | $14.00K | $83.38M | $708.00K | $-84.59M | $-1.90M | $-1.90M | 12 month · $634.00K | 12 month · $1.12M | 12 month · 120.30K | 12 month · 5.73 | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-01-31 | $14.00K | $83.12M | $708.00K | $-84.48M | $-2.06M | (m) | 9 month · $708.00K | 3 month · $379.00K | 9 month · 120.30K | 9 month · 5.73 | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-10-31 | $14.00K | $82.74M | $708.00K | $-81.95M | $93.00K | (m) | 6 month · $708.00K | 3 month · $53.00K | 6 month · 120.30K | 6 month · 5.73 | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-07-31 | $14.00K | $82.45M | $676.00K | $-79.88M | $1.90M | (m) | 3 month · $676.00K | 3 month · $423.00K | 3 month · 115.00K | 3 month · 5.62 | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-04-30 | $14.00K | $82.01M | $74.00K | $-77.32M | $4.64M | (m) | 12 month · $74.00K | 12 month · $864.00K | 12 month · 14.00K | 12 month · 5.11 | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-01-31 | $14.00K | $81.81M | (m) | $-74.76M | $7.06M | (m) | (m) | 3 month · $331.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-10-31 | $14.00K | $81.47M | (m) | $-72.32M | $9.17M | (m) | (m) | 3 month · $119.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-07-31 | $14.00K | $81.27M | (m) | $-72.30M | $8.98M | (m) | (m) | 3 month · $206.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-04-30 | $14.00K | $81.06M | $0.00 | $-71.98M | $9.10M | (m) | (m) | 12 month · $912.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-01-31 | $14.00K | $80.86M | (m) | $-71.64M | $9.24M | (m) | (m) | 3 month · $310.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-10-31 | $14.00K | $80.48M | (m) | $-72.42M | $8.07M | (m) | (m) | 3 month · $134.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-07-31 | $13.00K | $80.23M | (m) | $-72.70M | $7.54M | (m) | (m) | 3 month · $280.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-04-30 | $13.00K | $79.94M | (m) | $-72.53M | $7.43M | (m) | (m) | 12 month · $598.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-01-31 | $13.00K | $79.71M | (m) | $-71.64M | $8.09M | (m) | (m) | 3 month · $232.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-10-31 | $13.00K | $79.48M | (m) | $-72.60M | $6.89M | (m) | (m) | 3 month · $85.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-07-31 | $13.00K | $78.10M | (m) | $-72.60M | $5.51M | (m) | (m) | 3 month · $120.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-04-30 | $13.00K | $77.98M | (m) | $-72.89M | $5.10M | (m) | (m) | 12 month · $600.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-01-31 | $12.00K | $73.79M | (m) | $-70.62M | $5.51M | (m) | (m) | 3 month · $120.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-10-31 | $12.00K | $73.13M | (m) | $-71.03M | $2.11M | (m) | (m) | 3 month · $77.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-07-31 | $12.00K | $73.06M | (m) | $-71.34M | $1.73M | (m) | (m) | 3 month · $131.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-04-30 | $12.00K | $72.92M | (m) | $-70.70M | $2.14M | (m) | (m) | 12 month · $636.00K | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | 0.00 |
| 2019-01-31 | $12.00K | $72.76M | (m) | $-70.44M | $2.32M | (m) | (m) | 3 month · $335.00K | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | 0.00 |
| 2018-10-31 | $11.00K | $72.06M | (m) | $-70.08M | $1.99M | (m) | (m) | 3 month · $88.00K | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | 269.69K |
| 2018-07-31 | $11.00K | $72.19M | (m) | $-70.34M | $603.00K | (m) | (m) | 3 month · $75.00K | (m) | (m) | (m) | (m) | $1.25M | (m) | (m) | (m) | 269.69K |
| 2018-04-30 | $11.00K | $72.07M | (m) | $-70.83M | $3.00K | (m) | (m) | 12 month · $1.00M | (m) | (m) | (m) | (m) | $1.25M | (m) | (m) | (m) | 269.69K |
| 2018-01-31 | $11.00K | $71.91M | (m) | $-70.19M | $472.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.25M | (m) | (m) | (m) | 269.69K |
| 2017-10-31 | $11.00K | $71.73M | (m) | $-70.12M | $373.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.25M | (m) | (m) | (m) | 269.69K |
| 2017-07-31 | $11.00K | $71.56M | (m) | $-70.02M | $290.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.25M | (m) | (m) | (m) | 269.69K |
| 2017-04-30 | $11.00K | $70.99M | (m) | $-69.35M | $400.00K | (m) | (m) | 12 month · $2.66M | (m) | (m) | (m) | (m) | $1.25M | (m) | (m) | (m) | 269.69K |
| 2017-01-31 | $11.00K | $70.21M | (m) | $-66.92M | $2.04M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.25M | (m) | (m) | (m) | 269.69K |
| 2016-10-31 | $11.00K | $69.96M | (m) | $-65.52M | $3.21M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.25M | (m) | (m) | (m) | 269.69K |
| 2016-07-31 | $11.00K | $69.43M | (m) | $-65.01M | $3.18M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.25M | (m) | (m) | (m) | 269.69K |
| 2016-04-30 | $9.00K | $63.95M | (m) | $-62.47M | $238.00K | (m) | (m) | 12 month · $2.60M | (m) | (m) | (m) | (m) | $1.25M | (m) | 12 month · $18.00K | (m) | 269.69K |
| 2016-01-31 | $9.00K | $63.39M | (m) | $-59.89M | $2.26M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.25M | (m) | (m) | (m) | 269.69K |
| 2015-10-31 | $9.00K | $62.83M | (m) | $-57.48M | $4.10M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.25M | (m) | (m) | (m) | 269.69K |
| 2015-07-31 | $9.00K | $62.08M | (m) | $-54.93M | $5.90M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.25M | (m) | (m) | (m) | 269.69K |
| 2015-04-30 | $9.00K | $61.32M | (m) | $-52.02M | $8.06M | (m) | (m) | 12 month · $2.95M | (m) | (m) | (m) | (m) | $1.25M | (m) | (m) | 12 month · $1.62M | 269.69K |
| 2015-01-31 | $70.00K | $45.39M | (m) | $-48.35M | $-4.14M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.25M | (m) | (m) | (m) | 3.24M |
| 2014-10-31 | $70.00K | $44.89M | (m) | $-45.56M | $-1.86M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.25M | (m) | (m) | (m) | 3.24M |
| 2014-07-31 | $70.00K | $44.07M | (m) | $-42.45M | $439.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.25M | (m) | (m) | (m) | 3.24M |
| 2014-04-30 | $70.00K | $43.26M | (m) | $-38.88M | $3.20M | (m) | (m) | 12 month · $2.81M | (m) | (m) | (m) | (m) | $1.25M | $0.00 | (m) | (m) | 3.24M |
| 2014-01-31 | $70.00K | $42.41M | (m) | $-36.62M | $4.49M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.25M | $-124.00K | (m) | (m) | 3.24M |
| 2013-10-31 | $39.00K | $24.62M | (m) | $-36.02M | $-12.74M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.25M | $-124.00K | (m) | (m) | 3.24M |
| 2013-07-31 | $39.00K | $24.13M | (m) | $-33.70M | $-10.89M | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | $1.25M | $-111.00K | (m) | (m) | 3.24M |
| 2013-04-30 | $39.00K | $23.58M | (m) | $-31.47M | $-9.21M | (m) | (m) | 12 month · $2.38M | (m) | (m) | $0.00 | (m) | $1.25M | $-100.00K | (m) | (m) | 3.24M |
| 2013-01-31 | $39.00K | $23.14M | (m) | $-29.43M | $-7.60M | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | $1.25M | $-99.00K | (m) | (m) | 3.24M |
| 2012-10-31 | $38.00K | $22.57M | (m) | $-28.44M | $-7.18M | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | $1.25M | $-98.00K | (m) | (m) | 3.24M |
| 2012-07-31 | $38.00K | $21.94M | (m) | $-26.47M | $-5.84M | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | $1.25M | $-100.00K | (m) | (m) | 3.24M |
| 2012-04-30 | $38.00K | $21.20M | (m) | $-25.14M | $-5.28M | (m) | (m) | 12 month · $3.32M | (m) | (m) | $0.00 | (m) | $1.25M | $-125.00K | (m) | (m) | 3.24M |
| 2012-01-31 | $38.00K | (m) | (m) | $-22.59M | $-3.38M | (m) | (m) | (m) | (m) | (m) | $0.00 | $20.49M | $1.25M | $-67.00K | (m) | (m) | 3.24M |
| 2011-10-31 | $37.00K | (m) | (m) | $-20.87M | $-2.39M | (m) | (m) | (m) | (m) | (m) | $0.00 | $19.75M | $1.25M | $-53.00K | (m) | (m) | 3.24M |
| 2011-07-31 | $37.00K | (m) | (m) | $-18.52M | $-992.00K | (m) | (m) | (m) | (m) | (m) | $0.00 | $18.80M | $1.25M | $-60.00K | (m) | (m) | 3.24M |
| 2011-04-30 | $37.00K | $17.78M | (m) | $-16.48M | $19.00K | (m) | (m) | 12 month · $3.13M | (m) | (m) | $0.00 | $17.78M | $1.25M | $-68.00K | (m) | (m) | 3.24M |
| 2010-04-30 | (m) | (m) | (m) | (m) | $1.58M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |